Keyphrases
Clinical Management
100%
Patient Management
100%
Intravenous Lidocaine
100%
Long QT Syndrome Type 3
100%
LQT3
66%
Intravenous Lidocaine Infusion
22%
Mayo Clinic
11%
Retrospective Review
11%
Therapeutic Potential
11%
Treatment Options
11%
Bolus
11%
Implantable Defibrillator
11%
Seizure
11%
Pharmacotherapy
11%
Cardiac Transplantation
11%
Ventricular Arrhythmia
11%
Ventricular Ectopy
11%
Premature Ventricular Complexes
11%
Cardiac Events
11%
Action Potential
11%
Orthotopic Heart Transplantation
11%
Bridge to Transplantation
11%
Dizziness
11%
Torsades Des Pointes
11%
Device Therapy
11%
Cardiac Ablation
11%
Cardiac Denervation
11%
Lidocaine Infusion
11%
SCN5A
11%
Cardiac Sympathetic Denervation
11%
Prolonged Action
11%
Cumulative Time
11%
Gain-of-function Variant
11%
Medicine and Dentistry
Clinical Management
100%
Lidocaine
100%
Long QT Syndrome 3
100%
Infusion
25%
Heart Transplantation
16%
Epileptic Seizure
8%
Implantable Automatic Defibrillator
8%
Drug Therapy
8%
Denervation
8%
Premature Ventricular Contraction
8%
Heart Ventricle Arrhythmia
8%
Catheter Ablation
8%
Device Therapy
8%
Dizziness
8%
Torsade Des Pointes
8%
Action Potential
8%
Heart Denervation
8%
Side Effect
8%
Treatment Option
8%
Nursing and Health Professions
Clinical Management
100%
Lidocaine
100%
Long QT Syndrome 3
100%
Infusion
25%
Heart Transplantation
16%
Drug Therapy
8%
Heart Ventricle Extrasystole
8%
Heart Ventricle Arrhythmia
8%
Cardiac Event
8%
Dizziness
8%
Device Therapy
8%
Implantable Cardioverter Defibrillator
8%
Long Term Care
8%
Torsade Des Pointes
8%
Denervation
8%
Action Potential
8%
Heart Denervation
8%
Side Effect
8%
Pharmacology, Toxicology and Pharmaceutical Science
Lidocaine
100%
Long QT Syndrome 3
100%
Pharmacotherapy
8%
Heart Ventricle Extrasystole
8%
Heart Ventricle Arrhythmia
8%
Dizziness
8%
Torsade Des Pointes
8%
Side Effect
8%